Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Clinical Monitoring and Computing
Erschienen in: Journal of Clinical Monitoring and Computing 5/2018

16.10.2017 | Review Paper

Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients

verfasst von: Samir G. Sakka

Erschienen in: Journal of Clinical Monitoring and Computing | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Indocyanine green (ICG) is a water-soluble dye that is bound to plasma proteins when administered intravenously and nearly completely eliminated from the blood by the liver. ICG elimination depends on hepatic blood flow, hepatocellular function and biliary excretion. ICG elimination is considered as a useful dynamic test describing liver function and perfusion in the perioperative setting, i.e., in liver surgery and transplantation, as well as in critically ill patients. ICG plasma disappearance rate (ICG-PDR) which can be measured today by transcutaneous systems at the bedside is a valuable method for dynamic assessment of liver function and perfusion, and is regarded as a valuable prognostic tool in predicting survival of critically ill patients, presenting with sepsis, ARDS or acute liver failure.
Literatur
1.
Sakka SG, Reinhart K, Meier-Hellmann A. Does the optimization of cardiac output by fluid loading increase splanchnic blood flow?. Br J Anaesth. 2001;86:657–62.CrossRefPubMed
2.
Kortgen A, Lindemann W, Bauer M. Monitoring of plasma disappearance rate of indocyanine green in a patient with necrotizing fasciitis and septic shock. Dtsch Med Wochenschr. 2004;129:2590–3.CrossRefPubMed
3.
Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in critically ill patients-a prospective multicenter study. Crit Care Med. 2007;35:1099–104.CrossRefPubMed
4.
5.
Paumgartner G. Kinetics of indocyanine green removal from the blood. Ann N Y Acad Sci. 1970;170:134.CrossRef
6.
Paumgartner G. The handling of indocyanine green by the liver. Schweizer Med Wschr. 1975;105(Suppl):1–30.
7.
Cherrik GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observation on its physical properties, plasma decay and hepatic extraction. J Clin Invest. 1960;39:592–600.CrossRef
8.
Benya R, Quintana J, Brundage B. Adverse reactions to indocyanine green: a case report and a review of the literature. Cath Cardiovasc Diag. 1989;17:231–3.CrossRef
9.
Uusaro A, Ruokonen E, Takala J. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res. 1995;30:106–12.CrossRefPubMed
10.
Meijer DK, Weert B, Vermeer GA. Pharmacokinetics of biliary excretion in man. VI. Indocyanine green. Eur J Clin Pharmacol. 1988;35:295–303.CrossRefPubMed
11.
Sakka SG, van Hout N. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med. 2006;32:766–9.CrossRefPubMed
12.
Reekers M, Simon MJ, Boer F, Mooren RA, van Kleef JW, Dahan A, Vuyk J. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients. Anesth Analg. 2010;110:466–72.CrossRefPubMed
13.
Reichen J. Quantitative liver tests in living liver donors and their recipients. Liver Transpl. 2006;12:514–5.CrossRefPubMed
14.
Janssen MW, Druckrey-Fiskaaen KT, Omidi L, et al. Indocyanine green R15 ratio depends directly on liver perfusion flow rate. J Hepatobil Pancreat Surg. 2010;17:180–5.CrossRef
15.
de Graaf W, Häusler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik TM. Stieger B.Transporters involved in the hepatic uptake of (99 m)tc-mebrofenin and indocyanine green. J Hepatol. 2011;54:738–45.CrossRefPubMed
16.
Nanashima A, Abo T, Tobinaga S, Nonaka T, Fukuoka H, Hidaka S, Takeshita H, Sawai T, Yasutake T, Nagayasu T, Kudo T. Prediction of indocyanine green retention rate at 15 min by correlated liver function parameters before hepatectomy. J Surg Res. 2011;169:e119–25.CrossRefPubMed
17.
Stehr A, Ploner F, Traeger K, Theisen M, Zuelke C, Radermacher P, Matejovic M. Plasma disappearance of indocyanine green: a marker for excretory liver function? Intensive Care Med. 2005;31:1719–22.CrossRefPubMed
18.
Kuntz HD, Schregel W. Indocyanine green: evaluation of liver function - application in intensive care medicine. In: Lewis FR, Pfeiffer UJ, editors. Practical applications of fiberoptics in critical care monitoring. Berlin: Springer; 1990. pp. 57–62.CrossRef
19.
Pfeiffer UJ, Backus G, Bluemel G, et al. A fiberoptics-based system for integrated monitoring of cardiac output, intrathoracic blood volume, extravascular lung water, O2 saturation, and a-v differences. In: Lewis FR, Pfeiffer UJ, editors. Practical applications of fiberoptics in critical care monitoring. Berlin: Springer, 1990. pp. 114–25.CrossRef
20.
Kisch H, Leucht S, Lichtwarck-Aschoff M, Pfeiffer UJ. Accuracy and reproducibility of the measurement of actively circulating blood volume with an integrated fiberoptic monitoring system. Crit Care Med. 1995;23:885–93.CrossRefPubMed
21.
Scholz M, Wietasch G, Cuhls H, Giannaris S, Hoeft A. Bedside assessment of liver function by in vivo measurement of indocyanine green plasma disappearance rate (ICG-PDR). Anesthesiology. 1999;91:A515.
22.
Leevy CM, Smith F, Longueville J, Paumgartner G, Howard MM. Indocyanine green clearance as a test for hepatic function: evaluation by dichromatic ear densitometry. JAMA. 1967;200:236–40.CrossRefPubMed
23.
Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl. 2004;10:1060–4.CrossRefPubMed
24.
Sakka SG, Reinhart K, Meier-Hellmann A. Comparison between invasive and non-invasive measurement of indocyanine-green plasma disappearance rate in critically ill patients with mechanical ventilation and stable haemodynamics. Intensive Care Med. 2000;26:1553–6.CrossRefPubMed
25.
Sakka SG, Koeck H, Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med. 2004;30:506–9.CrossRefPubMed
26.
Thümer O, Hüttemann E, Sakka SG. Indocyanine green plasma disappearance rate. Marker of partial hepato-splanchnic ischemia. Anaesthesist. 2007;56:339–44.CrossRefPubMed
27.
Seibel A, Zimmerschied B, Grensemann J, Defosse J, Sakka SG. Measurement of indocyanine green plasma disappearance rate during running renal replacement therapy. Anaesth Intensive Care. 2012;40:733–5.PubMed
28.
Ameloot K, Meersseman P, Wilmer A, Hermans G, Gerits A, Spriet I, Wauters J. The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green. Intensive Care Med. 2013;39:2231–2.CrossRefPubMed
29.
Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg. 1999;86:1012–7.CrossRefPubMed
30.
Poon RT, Fan ST, Lo CM, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?. Ann Surg. 2002;236:602–11.CrossRefPubMedPubMedCentral
31.
Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255–9.CrossRefPubMed
32.
Wiegand BD, Ketterer SG, Rapaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis. 1960;5:427–36.CrossRefPubMed
33.
Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. NEJM. 2007;356:1545–59.CrossRefPubMed
34.
Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515–8.CrossRefPubMed
35.
Nonami T, Nakao A, Kurokawa T, et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology. 1999;46:1669–72.PubMed
36.
Poon RT, Fan ST. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobil Pancreat Surg. 2005; 12:31–7.CrossRef
37.
Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984–92.CrossRefPubMed
38.
Haegele S, Reiter S, Wanek D, Offensperger F, Pereyra D, Stremitzer S, Fleischmann E, Brostjan C, Gruenberger T, Starlinger P. Perioperative non-invasive indocyanine green-clearance testing to predict postoperative outcome after liver resection. PLoS ONE. 2016;11:e0165481.CrossRefPubMedPubMedCentral
39.
Ohwada S, Kawate S, Hamada K, et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg. 2006;93:339–46.CrossRefPubMed
40.
Greco E, Nanji S, Bromberg IL, et al. Predictors of peri-operative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease. HPB 2011;13:559–65.CrossRefPubMedPubMedCentral
41.
Nanashima A, Tobinaga S, Abo T, et al. Relationship of hepatic functional parameters with changes of functional liver volume using technetium-99 m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization: a follow-up report. J Surg Res. 2010;164:e235–42.CrossRefPubMed
42.
Sugimoto H, Okochi O, Hirota M, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry. J Hepatobiliary Pancreat Surg. 2006;13:543–8.CrossRefPubMed
43.
Niemann CU, Roberts JP, Ascher NL, Yost CS. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl. 2002;8:1126–32.CrossRefPubMed
44.
Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res. 2002;103:109–13.CrossRefPubMed
45.
Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.CrossRefPubMed
46.
Akita H, Sasaki Y, Yamada T, et al. Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry. World J Surg. 2008;32:2668–74.CrossRefPubMed
47.
Orii R, Sugawara Y, Hayashida M, et al. Lactate is correlated with the indocyanine green elimination rate in liver resection for cirrhotic patients. Anesth Analg. 2001;92:1064–70.CrossRefPubMed
48.
Oellerich M, Burdelski M, Lautz H-U, et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation. 1991;51:801–6.CrossRefPubMed
49.
Jalan RJ, Plevris JN, Jalan AR, Finlayson NDC, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation. 1994;58:196–200.CrossRefPubMed
50.
Wesslau C, Krueger R, May G. Clinical investigations using indocyanine green clearance for evaluation of liver function in organ donors. Transplantology. 1994;5:1–3.
51.
Schneider L, Spiegel M, Latanowicz S, Weigand MA, Schmidt J, Werner J, Stremmel W, Eisenbach C. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:362–8.CrossRefPubMed
52.
Hori T, Iida T, Yagi S, Taniguchi K, Yamamoto C, Mizuno S, Yamagiwa K, Isaji S, Uemoto S. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl. 2006;12:605–13.CrossRefPubMed
53.
Olmedilla L, Perez-Pena JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl. 2009;15:1247–53.CrossRefPubMed
54.
Levesque E, Saliba F, Benhamida S, et al. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl. 2009;15:1358–64.CrossRefPubMed
55.
Hoeft A. Transpulmonary indicator dilution: an alternative approach for hemodynamic monitoring. In: Vincent J-L, editor. Yearbook of intensive care and emergency medicine. Berlin: Springer; 1995. pp. 593–605.CrossRef
56.
Krenn CG, Schäfer B, Berlakovich GA, Steininger R, Steltzer H, Spiss CK. Detection of graft nonfunction after liver transplantation by assessment of indocyanine green kinetics. Anesth Analg. 1998;87:34–6.PubMed
57.
Jochum C, Beste M, Penndorf V, Farahani MS, Testa G, Nadalin S, Malago M, Broelsch CE, Gerken G. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl. 2006;12:544–9.CrossRefPubMed
58.
Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol. 2009;9:91.CrossRefPubMedPubMedCentral
59.
Quintero J, Miserachs M, Ortega J, Bueno J, Dopazo C, Bilbao I, Castells L, Charco R. Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure. Liver Int. 2014;34:689–94.CrossRefPubMed
60.
Gottlieb ME, Stratton HH, Newell JC, Shah DM. Indocyanine green—its use as an early indicator of hepatic dysfunction following injury in man. Arch Surg. 1984;119:264–8.CrossRefPubMed
61.
Pollack DS, Sufian S, Matsumoto T. Indocyanine green clearance in critically ill patients. Surg Gynecol Obstet. 1979;149:852–4.PubMed
62.
Ritz R, Cavanilles J, Michaels S, Shubin H, Weil MH. Disappearance of indocyanine green during circulatory shock. Surg Gynecol Obstet. 1973;136:57–62.PubMed
63.
Kholoussy AM, Pollack D, Matsumoto T. Prognostic significance of indocyanine green clearance in critically ill surgical patients. Crit Care Med. 1984;12:115–6.CrossRefPubMed
64.
Krassler J, Meier-Hellmann A, Bloos F, Reinhart K. Monitoring of the plasma disappearance rate (PDR) by indocyanine green (ICG) as a prognostic marker in critically ill patients. Intensive Care Med. 1996;22(Suppl 3):S361.CrossRef
65.
Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest. 2002;122:1715–20.CrossRefPubMed
66.
Sakka SG, Meier-Hellmann A. Indocyanine green for the assessment of liver function in critically ill patients. In: Vincent J-L, editor. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer; 2001. pp. 611–8.
67.
Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med. 2001;29:1159–63.CrossRefPubMed
68.
Poeze M, Solberg BC, Greve JW, Ramsay G. Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: What is a better predictor of outcome in critically ill septic patients?. Crit Care Med. 2005;33:2494–500.CrossRefPubMed
69.
Weis F, Kilger E, Beiras-Fernandez A, et al. Indocyanine green clearance as an outcome prediction tool in cardiac surgery: a prospective study. J Crit Care. 2014;29:224–9.CrossRefPubMed
70.
Sander M, Spies CD, Berger K, et al. Perioperative indocyanine green clearance is predictive for prolonged intensive care unit stay after coronary artery bypass grafting—an observational study. Crit Care. 2009;13:R149.CrossRefPubMedPubMedCentral
71.
Malbrain ML, Chiumello D, Cesana BM, Reintam Blaser A, Starkopf J, Sugrue M, Pelosi P, Severgnini P, Hernandez G, Brienza N, Kirkpatrick AW, Schachtrupp A, Kempchen J, Estenssoro E, Vidal MG, De Laet I, De Keulenaer BL. WAKE-Up! Investigators. A systematic review and individual patient data meta-analysis on intra-abdominal hypertension in critically ill patients: the wake-up project. World initiative on Abdominal Hypertension Epidemiology, a Unifying Project (WAKE-Up!). Minerva Anestesiol. 2014;80:293–306.PubMed
72.
Malbrain ML, Viaene D, Kortgen A, et al. Relationship between intra-abdominal pressure and indocyanine green plasma disappearance rate: hepatic perfusion may be impaired in critically ill patients with intra-abdominal hypertension. Ann Intensive Care. 2012;2(Suppl 1):S19.CrossRefPubMedPubMedCentral
73.
Seibel A, Sakka SG. Indocyanine green plasma disappearance rate: estimation of abdominal perfusion disturbances. Anaesthesist. 2010;59:1091–8.CrossRefPubMed
74.
Joly LM, Monchi M, Cariou A, Chiche JD, Bellenfant F, Brunet F, Dhainaut JF. Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med. 1999;160:1983–6.CrossRefPubMed
75.
Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med. 1997;25:236–42.CrossRefPubMed
76.
Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med. 2000;28:3799–807.CrossRefPubMed
77.
Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Vogt J, Wachter U, Weiss M, Altin C, Georgieff M, Radermacher P. Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med. 2001;27:1179–86.CrossRefPubMed
78.
Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med. 2000;26:1557–60.CrossRefPubMed
79.
Birnbaum J, Lehmann C, Taymoorian K, Krausch D, Wauer H, Gründling M, Spies C, Kox WJ. The effect of dopexamine and iloprost on plasma disappearance rate of indocyanine green in patients in septic shock. Anaesthesist. 2003;52:1014–9.CrossRefPubMed
Metadaten
Titel
Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients
verfasst von
Samir G. Sakka
Publikationsdatum
16.10.2017
Verlag
Springer Netherlands
Erschienen in
Journal of Clinical Monitoring and Computing / Ausgabe 5/2018
Print ISSN: 1387-1307
Elektronische ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-017-0073-4

Weitere Artikel der Ausgabe 5/2018

Journal of Clinical Monitoring and Computing 5/2018 Zur Ausgabe

Original Research

Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological and neurosurgical patients

Original Research

In vitro performance of prefilled CO2 absorbers with the Zeus®

Original Research

Effects of ultrasound-guided stellate-ganglion block on sleep and regional cerebral oxygen saturation in patients undergoing breast cancer surgery: a randomized, controlled, double-blinded trial

Editorial

The challenge of exploring organ function: knowledge is not care, but care needs knowledge!

Original Research

Video-based heart rate monitoring across a range of skin pigmentations during an acute hypoxic challenge

Original Research

An observational study of the optimal placement of a cerebral oximeter probe to avoid the frontal sinus in children

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

23.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren